Edward Kaplan, MD
Radiation Oncology · Coconut Creek, FLNPI 1477587830
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $55,172 of the $56,268 with a category attached, or 98.1%. C. R. Bard, Inc. & Subsidiaries accounts for 98.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $14,629 and has fallen 99.3% since, to $100 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $1223.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- C. R. Bard, Inc. & Subsidiaries$55K
- Theragenics Corporation$457
- Novocure Inc.$102
- Seagen Inc.$100
- Siemens Medical Solutions USA, Inc.$86
- Elekta, Inc.$85
- plus $266 from 8 others
What the payments were for
- Royalty or licence$55,17298%
- Food & beverage$9952%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries | 23 | $55,172 |
| Theragenics Corporation | 3 | $457 |
| Novocure Inc. | 4 | $102 |
| Seagen Inc. | 1 | $100 |
| Siemens Medical Solutions USA, Inc. | 1 | $86 |
| Elekta, Inc. | 1 | $85 |
| Novo Nordisk | 4 | $58 |
| Medtronic | 2 | $56 |
| Blue Earth Diagnostics | 2 | $46 |
| GT Medical Technologies, Inc | 1 | $40 |
| Brainlab, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $17 |
| Isoray, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,268 in reported general payments places this provider in the 95th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 25 | $64,492 |
| Bicalutamide | 86 | $2,350 |
| Megestrol Acetate | 30 | $1,086 |
| Tamsulosin Hcl | 117 | $916 |
| Tolterodine Tartrate ErTolterodine Tartrate | 25 | $714 |
| SsdSilver Sulfadiazine | 14 | $462 |
| Ciprofloxacin Hcl | 23 | $82 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Coconut Creek
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
- Akash NandaOrlando$165K
- Michael ChuongMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.